Harnal

Astellas May Sell Over-the-Counter Drug Unit, People Say Dec 14, 2005
Bloomberg 30, Astellas' net income rose 42 percent from a year earlier to 67.3 billion yen on overseas demand for its Harnal prostate treatment and Prograf organ ...

Astellas May Sell Over-Counter Drug Unit, People Say (Update2) Dec 14, 2005
Bloomberg The maker of the Harnal prostate treatment and Prograf organ-transplant drug is counting on Vesicare, a urinary-disorder treatment to boost profit. ...